Elucidating the unexplained underperformance syndrome in endurance athletes: The interleukin-6 hypothesis

Sports Medicine

Volumn 33, Issue 10, 2003, Pages 771-781

  Robson, Paula J ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b The Priory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ATHLETE; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; ENDOTOXEMIA; ENDURANCE; EXERCISE; FATIGUE; GENETIC PREDISPOSITION; HEAT STRESS; HEAT STROKE; HUMAN; HYPOGLYCEMIA; INFECTION; MENTAL STRESS; OVEREXERTION; REVIEW; SYNDROME; TRAINING; UNEXPLAINED UNDERPERFORMANCE SYNDROME;

FATIGUE; HUMANS; INTERLEUKIN-6; PHYSICAL ENDURANCE; SPORTS; STRESS, PSYCHOLOGICAL; SYNDROME;

EID: 0043163562     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200333100-00004     Document Type: Review

References (76)

1. Budgett R, Newsholme E, Lehmann M, et al. Redefining the overtraining syndrome as the unexplained underperformance syndrome. Br J Sports Med 2000; 34 (1): 67-8
2. Fry RW, Morton AR, Keast D. Overtraining in athletes: an update. Sports Med 1991; 12 (1): 32-65
3. Smith LL. Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress? Med Sci Sports Exerc 2000; 32 (2): 317-31
4. Kishimoto T. The biology of interleukin-6. Blood 1989; 74 (1): 1-10
5. Pedersen BK, Steensberg A, Fischer C, et al. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 2001; 7: 18-31
6. Pedersen BK, Steensberg A, Schjerling P. Exercise and interleukin-6. Curr Opin Hematol 2001; 8 (3): 137-41
7. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997; 15: 797-819
8. Van Wagoner NJ, Oh JW, Repovic P, et al. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 1999; 19 (13): 5236-44
9. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, et al. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 1998; 30 (5): 671-8
10. Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515 (Pt 1): 287-91
11. Ullum H, Haahr PM, Diamant M, et al. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pm-mRNA in BMNC. J Appl Physiol 1994; 77 (1): 93-7
12. Sondergaard SR, Ostrowski K, Ullum H, et al. Changes in plasma concentrations of interleukin-6 and interleukin-1 receptor antagonists in response to adrenaline infusion in humans. Eur J Appl Physiol 2000; 83 (1): 95-8
13. Nehlsen-Cannarella SL, Fagoaga OR, Nieman DC, et al. Carbohydrate and the cytokine response to 2.5h of running. J Appl Physiol 1997; 82 (5): 1662-7
14. Bishop NC, Walsh NP, Haines DL, et al. Pre-exercise carbohydrate status on immune responses to prolonged cycling: II. Effect on plasma cytokine concentration. Int J Sport Nutr Exerc Metab 2001; 11 (4): 503-12
15. Steensberg A, van Hall G, Osada T, et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000; 529 Pt 1: 237-42
16. Starkie RL, Angus DJ, Rolland J, et al. Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans. J Physiol 2000; 528 (Pt 3): 647-55
17. Steensberg A, Toft AD, Schjerling P, et al. Plasma interleukin-6 during strenuous exercise: role of epinephrine. Am J Physiol Cell Physiol 2001; 281 (3): C1001-4
18. Jonsdottir IH, Schjerling P, Ostrowski K, et al. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 2000; 528 Pt 1: 157-63
19. Ostrowski K, Rohde T, Zacho M, et al. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998; 508 (Pt 3): 949-53
20. Starkie RL, Arkinstall MJ, Koukoulas I, et al. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 2001; 533 (Pt 2): 585-91
21. Banks WA, Kastin AJ, Gutierrez EG. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 1994; 179 (1-2): 53-6
22. Schobitz B, Voorhuis DA, de Kloet ER. Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci Lett 1992; 136 (2): 189-92
23. Matta SG, Weatherbee J, Sharp BM. A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1 beta. Neuroendocrinology 1992; 56 (4): 516-25
24. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission: comparison with the effects of stress. Adv Exp Med Biol 1999; 461: 117-27
25. Wang J, Dunn AJ. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int 1998; 33 (2): 143-54
26. Chai Z, Gatti S, Toniatti C, et al. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J Exp Med 1996; 183 (1): 311-6
27. Schobitz B, Pezeshki G, Pohl T, et al. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J 1995; 9 (8): 659-64
28. Maes M, Lin AH, Delmeire L, et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999; 45 (7): 833-9
29. Baker DG, Ekhator NN, Kasckow JW, et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 2001; 9 (4): 209-17
30. Jones SA, Horiuchi S, Topley N, et al. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001; 15 (1): 43-58
31. Oh JW, Van Wagoner NJ, Rose-John S, et al. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol 1998; 161 (9): 4992-9
32. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000; 95 (1): 56-61
33. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92 (6 Suppl.): 1684-8
34. Budgett R. Fatigue and underperformance in athletes: the overtraining syndrome. Br J Sports Med 1998; 32 (2): 107-10
35. Heney D, Lewis IJ, Evans SW, et al. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165 (5): 886-90
36. Spath-Schwalbe E, Hansen K, Schmidt F, et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998; 83 (5): 1573-9
37. Kurzrock R. Cytokine deregulation in cancer. Biomed Pharmacother 2001; 55 (9-10): 543-7
38. Bell IR. White paper: neuropsychiatric aspects of sensitivity to low-level chemicals: a neural sensitization model. Toxicol Ind Health 1994; 10 (4-5): 277-312
39. Budgett R. Overtraining syndrome. Br J Sports Med 1990; 24 (4): 231-6
40. Derman W, Schwellnus MP, Lambert MI, et al. The 'worn-out athlete': a clinical approach to chronic fatigue in athletes. J Sports Sci 1997; 15 (3): 341-51
41. Urhausen A, Kindermann W. Diagnosis of overtraining: what tools do we have? Sports Med 2002; 32 (2): 95-102
42. Fry RW, Morton AR, Keast D. Periodisation and the prevention of overtraining. Can J Sport Sci 1992; 17 (3): 241-8
43. Maes M, Ombelet W, De Jongh R, et al. The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 2001; 63 (1-3): 85-92
44. Fry RW, Grove JR, Morton AR, et al. Psychological and immunological correlates of acute overtraining. Br J Sports Med 1994; 28 (4): 241-6
45. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149 (8): 999-1010
46. Oladehin A, Waters RS. Location and distribution of fos protein expression in rat hippocampus following acute moderate aerobic exercise. Exp Brain Res 2001; 137 (1): 26-35
47. Puntschart A, Wey E, Jostarndt K, et al. Expression of fos and jun genes in human skeletal muscle after exercise. Am J Physiol 1998; 274 (1 Pt 1): C129-37
48. Miyahara S, Komori T, Fujiwara R, et al: Effects of repeated stress on expression of interleukin-6 (IL-6) and IL- 6 receptor mRNAs in rat hypothalamus and midbrain. Life Sci 2000; 66 (6): L93-8
49. Wijsman JA, Shivers RR. Heat stress affects blood-brain barrier permeability to horseradish peroxidase in mice. Acta Neuropathol (Berl) 1993; 86 (1): 49-54
50. de Vries HE, Blom-Roosemalen MC, van Oosten M, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996; 64 (1): 37-43
51. Lustig S, Danenberg HD, Kafri Y, et al. Viral neuroinvasion and encephalitis induced by lipopolysaccharide and its mediators. J Exp Med 1992; 176 (3): 707-12
52. Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans: effect of intensity of exercise. Eur J Appl Physiol 2000; 83 (6): 512-5
53. Ronsen O, Lea T, Bahr R, et al. Enhanced plasma IL-6 and IL-1ra responses to repeated vs single bouts of prolonged cycling in elite athletes. J Appl Physiol 2002; 92 (6): 2547-53
54. Brock-Utne JG, Gaffin SL, Wells MT, et al. Endotoxaemia in exhausted runners after a long-distance race. S Afr Med J 1988; 73 (9): 533-6
55. Jeukendrup AE, Vet-Joop K, Sturk A, et al. Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci (Lond) 2000; 98 (1): 47-55
56. Penttila IA, Harris RJ, Storm P, et al. Cytokine dysregulation in the post-Q-fever fatigue syndrome. Q J Med 1998; 91 (8): 549-60
57. Vallieres L, Rivest S. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin: releasing factor during endotoxemia. Endocrinology 1999; 140 (9): 3890-903
58. Chung NK, Shabbir M, Lim CL. Cytokine levels in patients with previous heatstroke under heat stress. Mil Med 1999; 164 (4): 306-10
59. Hammami MM, Bouchama A, Al Sedairy S, et al. Concentrations of soluble tumor necrosis factor and interleukin-6 receptors in heatstroke and heatstress. Crit Care Med 1997; 25 (8): 1314-9
60. Maes M, Meltzer HY, Bosmans E, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34 (4): 301-9
61. Sluzewska A, Rybakowski J, Bosmans E, et al. Indicators of immune activation in major depression. Psychiatry Res 1996; 64 (3): 161-7
62. Song C, Kenis G, van Gastel A, et al. Influence of psychological stress on immune-inflammatory variables in normal humans: part II. Altered serum concentrations of natural antiinflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res 1999; 85 (3): 293-303
63. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabefic humans. Diabetes 1991; 40 (2): 223-6
64. Galassetti P, Mann S, Tate D, et al. Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab 2001; 280 (6): E908-17
65. Davis SN, Shavers C, Mosqueda-Garcia R, et al. Effects of differing antecedent hypoglycemia on subsequent counter-regulation in normal humans. Diabetes 1997; 46 (8): 1328-35
66. Path G, Scherbaum WA, Bornstein SR. The role of interleukin-6 in the human adrenal gland. Eur J Clin Invest 2000; 30 Suppl. 3:91-5
67. Tsigos C, Papanicolaou DA, Kyrou I, et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997; 82 (12): 4167-70
68. Liao J, Keiser JA, Scales WE, et al. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 1995; 268 (4 Pt 2): R896-901
69. Ritchie DG. Interleukin 6 stimulates hepatic glucose release from prelabeled glycogen pools. Am J Physiol 1990; 258 (1 Pt 1): E57-64
70. Wischnia B. Comeback at Comrades. Runners World 1994; 8: 76-7
71. Hooper SL, Mackinnon LT, Howard A, et al. Markers for monitoring overtraining and recovery. Med Sci Sports Exerc 1995; 27 (1): 106-12
72. Armstrong LE, VanHeest JL. The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology. Sports Med 2002; 32 (3): 185-209
73. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102 (7): 1369-76
74. Morgan WP, Costill DL, Flynn MG, et al. Mood disturbance following increased training in swimmers. Med Sci Sports Exerc 1988; 20 (4): 408-14
75. Rushall B. A tool for measuring stress tolerance in elite athletes. J Appl Sports Psychol 1990; 2: 64
76. Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis 2000; 59 Suppl. 1: i21-7